All
Search
Images
Videos
Shorts
Maps
News
Copilot
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
12:15
The Secrets of Successful Drug Launches: The Six Root Causes o
…
5 months ago
pharmexec.com
The Situation We Faced: Aaron Cowley, CSO, Recipharm Advance
…
1 month ago
pharmexec.com
Effective Real-World Evidence for Adding Value to a Clinical Trial | P
…
3 weeks ago
pharmexec.com
Specialty Pharmacists: Evolving from Dispensing Medications to S
…
1 month ago
pharmexec.com
What Trends Did You See at This Year's JP Morgan Healthcare Conf
…
3 weeks ago
pharmexec.com
How Are Sites Impacted by Poor Planning and Trial Design? | Phar
…
1 month ago
pharmexec.com
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan H
…
1 month ago
pharmexec.com
What is Daiichi Sankyo’s Post JP Morgan Strategy? | PharmExec
3 weeks ago
pharmexec.com
What Defined 2025 for Re-Vana? | PharmExec
1 month ago
pharmexec.com
Operational Challenges for Specialty Pharmacies | PharmExec
1 month ago
pharmexec.com
Reshaping Complex Therapy Delivery | PharmExec
1 month ago
pharmexec.com
The Challenges and Advantages of US Healthcare in a Worldwide Per
…
1 week ago
pharmexec.com
Making Integrated Care a Reality | PharmExec
1 month ago
pharmexec.com
How is Re-Vana Using its Sustained-Delivery Hydrogel Technology to
…
1 month ago
pharmexec.com
Framing the Value of AD109 | PharmExec
1 month ago
pharmexec.com
2:04
What's Causing So Many Phase III Trials to Head for Avoidable Failur
…
6 months ago
pharmexec.com
Regeneron’s DB-OTO: Overcoming Clinical and Manufacturing Hurdle
…
1 week ago
pharmexec.com
Leveraging Technology Without Compromising Patient Care | Phar
…
1 month ago
pharmexec.com
AbbVie Positions Temab-A ADC for Tumor-Agnostic Use in Multiple C
…
7 months ago
pharmexec.com
J&J Aims to Reduce Oncology Care Gaps Through Community Suppor
…
7 months ago
pharmexec.com
How Can AI Life Sciences Companies Stand Out at the Upco
…
1 month ago
pharmexec.com
Understanding Chronic Inflammation Through Viral Expos
…
10 months ago
pharmexec.com
What Trends Do You See in Neuroscience in 2026? | PharmExec
2 months ago
pharmexec.com
Emrelis Approval Highlights FDA Confidence in ADC Oncology Trea
…
7 months ago
pharmexec.com
How Do New GLP-1 Drugs Impact Businesses' Ability to Provide The
…
2 months ago
pharmexec.com
How Will Recent Regulatory Developments at FDA Impact Feas
…
2 months ago
pharmexec.com
Who Benefits from Direct-to-Consumer Drug Sales | PharmExec
5 months ago
pharmexec.com
Creating Effective Peptide-Based Therapeutics | PharmExec
4 months ago
pharmexec.com
Eisai Highlights Long-Term Efficacy of Lenvima in Advanced HCC Trea
…
7 months ago
pharmexec.com
2:30
What Trends Are You Seeing in Pharma Commercialization? | Pha
…
2 months ago
pharmexec.com
See more videos
More like this
Feedback